Case Studies
Nucleonics Raises $50 Million
Shay advises one of the leading developers of RNA interference-based therapeutics in its latest financing round
Related Practices
Related News [ more ]
- Duane Morris Welcomes IP Lawyer J. Donald McCarthy to Los Angeles Office
- Duane Morris Welcomes Trial Partner to Newark Office
- Duane Morris Welcomes Two Prominent IP Attorneys to San Diego Office
Upcoming Events
Past Events [ more ]
- Duane Morris Partner Alan Klein to Speak at ACI's 2nd Annual Conference on Preventing & Defending Chemical Product Liability Litigation
- Duane Morris Partner Rick Ball to Speak at Food and Drug Law Institute Conference
- Alan Klein to Speak at the Mealey's Defense Strategies in Pharmaceutical Litigation Conference
Related Publications [ more ]
- FDA Announces Draft Prescription Drug User Fee Act for Drug Safety Five-Year Plan
- Key Pharma Preemption Ruling in Third Circuit
- Pharmaceutical Manufacturers Be Aware
Related Matters Listing
Attorney Listing
Pharmaceutical & Biotechnology
From major multinational corporations seeking to expand market share to startups with ideas growing in the laboratory, life sciences companies of all levels of maturity turn to Duane Morris for counsel and representation aimed at improving their organizational health.
Our attorneys are experienced with the challenges posed by the development, manufacture, marketing and sales of medical devices, technology and drugs, and work with clients to quickly and effectively clear regulatory hurdles while striving to protect intellectual and monetary assets.
Working at the crossroads of science and business, many Duane Morris lawyers call upon their knowledge gained through previous positions as toxicologists, pharmacists and laboratory researchers, as well as their advanced degrees in biology, biochemistry and molecular and developmental genetics, when assessing clients' specialized legal needs.
Drawing from our hundreds of attorneys in numerous major markets, we are able to provide teams of lawyers who practice in diverse legal disciplines (such as patents and intellectual property, corporate finance and securities law, international trade and taxation, labor and employment law, products liability and other litigation), all of whom have experience handling matters for pharmaceutical and biotechnology clients.
For more information, please contact Nicholas J. Lynn, James G. Markey or any of the group members referenced in the Attorney Listing.